#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic microangiopathy Infantile spasms Cerebellar ataxia Langerhans' cell histiocytosis Stiff person syndrome Pyruvate dehydrogenase complex deficiency Bulbospinal muscular atrophy congenital Richter's syndrome Peritoneal mesothelioma malignant Follicular lymphoma stage III Vascular calcification Bladder cancer Cardiac arrest Vaginal cancer Acute respiratory distress syndrome More trials…

    Learn about Rare Diseases

    Medulloblastoma – Treatment Basal cell naevus syndrome – Trials in Disease Undifferentiated sarcoma – Trials in Disease Myxofibrosarcoma – Diagnostics Thrombotic thrombocytopenic purpura – Trials in Disease Skin angiosarcoma – Basic Information MELAS syndrome – Life with Disease Alagille syndrome Marginal zone lymphoma refractory – Life with Disease Cholangitis sclerosing – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Midodrine Hydrochloride Abbv-668 Balstilimab Ticagrelor Lithium Sulphate, Anhydrous Adrenaline Tartrate Ph. Eur. Parsaclisib Hydrochloride Cipepofol Tilmanocept Hydrochlorothiazide Foscarnet Macrogol 4000 Cefuroxime Carbamazepine Netupitant Sulfur Hexafluoride Bisoprolol Golodirsen Etelcalcetide Juniper Berry Oil More therapies…

    Learn about Your Condition

    Carotid arteriosclerosis Metastases to biliary tract Bone hypertrophy Anal cancer stage III Ovarian cancer stage IV Mucosal inflammation Skin cancer Cholangitis sclerosing Pancreatitis chronic Ebola disease External cephalic version Thermal burn Rett syndrome Gestational diabetes Plasma cell myeloma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

HIV infection

  • Study on Early Switching to Dolutegravir and Lamivudine for Adults with HIV-1 on Three-Drug Regimen with Virological Suppression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir
    • Lamivudine
    Italy

  • Study Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abacavir
    • Abacavir Sulfate
    • Cobicistat
    Germany The Netherlands Poland Spain

  • Study on Dolutegravir and Lamivudine for Maintaining Viral Control in Children with HIV Aged 2 to Under 15 Years

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Abacavir Sulfate
    • Dolutegravir Sodium
    • Lamivudine
    Spain

  • Study to Compare Weekly Islatravir/Lenacapavir with Bictegravir/Emtricitabine/Tenofovir in People with HIV-1 Who Are Virologically Suppressed

    Not recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Islatravir
    • Bictegravir
    • Emtricitabine
    France Germany Spain

  • Study on the Effectiveness of Doravirine and Dolutegravir for People with HIV Switching Antiretroviral Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Dolutegravir Sodium
    • Doravirine
    Italy

  • Study of Rilpivirine for Children and Teens with HIV-1 from Previous Rilpivirine Studies

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Rilpivirine
    Italy
Previous Page
1 … 5 6 7 8 9 … 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!